Back to Search Start Over

Proteome analysis of human Wharton's jelly cells during in vitro expansion.

Authors :
Angelucci, Stefania
Marchisio, Marco
Di Giuseppe, Fabrizio
Pierdomenico, Laura
Sulpizio, Marilisa
Eleuterio, Enrica
Lanuti, Paola
Sabatino, Giuseppe
Miscia, Sebastiano
Di Ilio, Carmine
Source :
Proteome Science; 2010, Vol. 8, p18-29, 12p
Publication Year :
2010

Abstract

Background: The human umbilical cord contains mucoid connective tissue and fibroblast-like cells. These cells named Wharton's jelly cells, (WJCs) display properties similar to mesenchymal stem cells therefore representing a rich source of primitive cells to be potentially used in regenerative medicine. Results: To better understand their self-renewal and potential in vitro expansion capacity, a reference 2D map was constructed as a proteomic data set. 158 unique proteins were identified. More than 30% of these proteins belong to cytoskeleton compartment. We also found that several proteins including Shootin1, Adenylate kinase 5 isoenzyme and Plasminogen activator-inhibitor 2 are no longer expressed after the 2<superscript>nd</superscript> passage of in vitro replication. This indicates that the proliferative potency of these cells is reduced after the initial stage of in vitro growing. At the end of cellular culturing, new synthesized proteins, including, ERO1-like protein alpha, Aspartyl-tRNA synthetase and Prolyl-4-hydroxylase were identified. It is suggested that these new synthesized proteins are involved in the impairment of cellular surviving during replication and differentiation time. Conclusions: Our work represents an essential step towards gaining knowledge of the molecular properties of WJCs so as to better understand their possible use in the field of cell therapy and regenerative medicine. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14775956
Volume :
8
Database :
Complementary Index
Journal :
Proteome Science
Publication Type :
Academic Journal
Accession number :
51178921
Full Text :
https://doi.org/10.1186/1477-5956-8-18